TB support in Swaziland


Eswatini (formerly Swaziland) has one of the world’s highest rates of HIV, with nearly one in three adults living with the disease. However, around 80 per cent of people with TB in Eswatini are HIV positive.

Estimates suggest that HIV incidence rates in Eswatini have fallen in recent years, as significant progress has been made in improving the number of people receiving antiretroviral (ARV) treatment.

We continue to help more HIV patients access ARV treatment through the ’test and start’ strategy. A team has been piloting ‘test and start’ in the Nhlangano project; after HIV testing, ARV treatment was offered to more than 1,700 people after a positive HIV diagnosis to immediately start treatment.

We now treat patients with extensively drug-resistant TB (XDR-TB), and those developing severe side effects, using the promising new drugs bedaquiline and delamanid in combination with repurposed drugs.

MSF teams are currently responding to the coronavirus COVID-19 pandemic in Eswatini.

In 2019
Bending the Curves - Eshowe HIV

MSF calls for quality HIV care in neglected communities

Press Release 18 Jul 2016
MSF HIV Testing Clinic's in Conakry

7 things you may believe about HIV/AIDS that turn out to be wrong

Project Update 19 Apr 2016
Swaziland - Figthing HIV and TB dual epidemic

Countries should take up new WHO ‘test and treat’ guidelines

Press Release 24 Nov 2015
Bangladeshis without borders, communication package 4 sept 2014

Bangladesh Without Borders: Reducing the burden of HIV and tuberculosis in Swaziland

Voices from the Field 4 Sep 2014

Surviving drug-resistant TB: “I’m still over the moon”

Project Update 24 Jul 2014
Swaziland - Figthing HIV and TB dual epidemic

Treating HIV and TB in Swaziland: “We didn’t know what to expect”

Voices from the Field 30 Jun 2014